Key result
BH4 virtually eliminates atherosclerosis in ApoE-deficient mice by recoupling NOS and improving endothelial vasodilation.
Why the study?
Does tetrahydrobiopterin treatment prevent endothelial dysfunction, plaque inflammation, and atherosclerosis in apolipoprotein E(-/-) mice with disturbed flow?
Does tetrahydrobiopterin treatment prevent endothelial dysfunction, plaque inflammation, and atherosclerosis in apolipoprotein E(-/-) mice with disturbed flow?
Tetrahydrobiopterin supplementation prevents atherosclerosis and vascular inflammation induced by disturbed flow in a preclinical model by recoupling endothelial nitric oxide synthase.
Does not support clinical BH4 use; leaves open human translation of NOS recoupling for atherosclerosis prevention.
OBJECTIVE: Tetrahydrobiopterin (BH(4)) is a critical cofactor for nitric oxide (NO) synthesis by NO synthase (NOS). Recently, we demonstrated that disturbed flow produced by partial carotid ligation decreases BH(4) levels in vivo. We therefore aimed to determine whether atherosclerosis induced by disturbed flow is due to BH(4) deficiency and NOS uncoupling and whether increasing BH(4) would prevent endothelial dysfunction, plaque inflammation, and atherosclerosis. METHODS AND RESULTS: We produced a region of disturbed flow in apolipoprotein E(-/-) mice using partial carotid ligation and fed these animals a high-fat diet. This caused endothelial NOS uncoupling as characterized by increased vascular superoxide production, altered vascular reactivity, and a change in endothelial NOS migration on low-temperature gel. These perturbations were accompanied by severe atherosclerosis, infiltration of T cells and macrophages, and an increase in cytokine production. Treatment with BH(4) recoupled NOS, decreased superoxide production, improved endothelium-dependent vasodilatation, and virtually eliminated atherosclerosis. BH(4) treatment also markedly reduced vascular inflammation and improved the cytokine milieu induced by disturbed flow. CONCLUSIONS: Our results highlight a key role of BH(4) deficiency and NOS uncoupling in atherosclerosis induced by disturbed flow and provide insight into the effect of modulating vascular BH(4) levels on atherosclerosis and inflammation at these sites of the circulation.
No takes yet. Share an insight, caveat, or question.
Li et al. (2011) studied Atherosclerosis. Tetrahydrobiopterin (BH4) vs. Untreated/control mice was evaluated on Endothelial dysfunction, plaque inflammation, and atherosclerosis. Treatment with BH4 recoupled NOS, decreased superoxide production, improved endothelium-dependent vasodilatation, and virtually eliminated atherosclerosis in apolipoprotein E(-/-) mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: